Miki Y - Search Results

1

Reduced levels of ATF-2 predispose mice to mammary tumors.

Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, Nagasaki K, Miki Y, Saito-Ohara F, Inazawa J, Kohno T, Yokota J, Ishii S. Maekawa T, et al. Among authors: miki y. Mol Cell Biol. 2007 Mar;27(5):1730-44. doi: 10.1128/MCB.01579-06. Epub 2006 Dec 22. Mol Cell Biol. 2007. PMID: 17189429 Free PMC article.

2

[Gene expression profiling for prediction of response to chemotherapy].

Shimoji T, Miki Y, Nagasaki K. Shimoji T, et al. Among authors: miki y. Gan To Kagaku Ryoho. 2006 Jan;33(1):1-5. doi: 10.2217/14750708.3.1.1. Gan To Kagaku Ryoho. 2006. PMID: 16410689 Review. Japanese.

3

Gene expression profiling of breast cancer.

Nagasaki K, Miki Y. Nagasaki K, et al. Among authors: miki y. Breast Cancer. 2006;13(1):2-7. doi: 10.2325/jbcs.13.2. Breast Cancer. 2006. PMID: 16518056 Free article. Review.

4

Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.

Yoshida K, Yamaguchi T, Shinagawa H, Taira N, Nakayama KI, Miki Y. Yoshida K, et al. Among authors: miki y. Mol Cell Biol. 2006 May;26(9):3414-31. doi: 10.1128/MCB.26.9.3414-3431.2006. Mol Cell Biol. 2006. PMID: 16611985 Free PMC article.

5

Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer.

Oishi Y, Nagasaki K, Miyata S, Matsuura M, Nishimura SI, Akiyama F, Iwai T, Miki Y. Oishi Y, et al. Among authors: miki y. J Hum Genet. 2007;52(3):271-279. doi: 10.1007/s10038-007-0111-z. Epub 2007 Feb 7. J Hum Genet. 2007. PMID: 17285241

6

Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage.

Liu H, Lu ZG, Miki Y, Yoshida K. Liu H, et al. Among authors: miki y. Mol Cell Biol. 2007 Dec;27(24):8480-91. doi: 10.1128/MCB.01126-07. Epub 2007 Oct 15. Mol Cell Biol. 2007. PMID: 17938203 Free PMC article.

7

Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.

Nagasaki K, Miki Y. Nagasaki K, et al. Among authors: miki y. Breast Cancer. 2008;15(2):117-20. doi: 10.1007/s12282-008-0031-6. Breast Cancer. 2008. PMID: 18274834 Review.

8

Identification of novel deletion polymorphisms in breast cancer.

Komatsu A, Nagasaki K, Fujimori M, Amano J, Miki Y. Komatsu A, et al. Among authors: miki y. Int J Oncol. 2008 Aug;33(2):261-70. Int J Oncol. 2008. PMID: 18636146

9

Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.

Ito Y, Nagasaki K, Miki Y, Iwase T, Akiyama F, Matsuura M, Horii R, Makita M, Tokudome N, Ushijima M, Yoshimoto M, Takahashi S, Noda T, Hatake K. Ito Y, et al. Among authors: miki y. Cancer Sci. 2011 Jan;102(1):130-6. doi: 10.1111/j.1349-7006.2010.01740.x. Epub 2010 Sep 30. Cancer Sci. 2011. PMID: 20880335 Free article. Clinical Trial.

10

Prognostic value of matrix Gla protein in breast cancer.

Yoshimura K, Takeuchi K, Nagasaki K, Ogishima S, Tanaka H, Iwase T, Akiyama F, Kuroda Y, Miki Y. Yoshimura K, et al. Among authors: miki y. Mol Med Rep. 2009 Jul-Aug;2(4):549-53. doi: 10.3892/mmr_00000135. Mol Med Rep. 2009. PMID: 21475864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,493 results

Search Page